Terapia génica para la taquicardia ventricular polimórfica catecolaminergica mediante la inhibición de la quinasa II dependiente de la calmodulina
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Ver abstracta en PubMed
Resumen
Este resumen es generado por máquina.La terapia génica suprimió eficazmente las arritmias en modelos de ratón con taquicardia ventricular polimórfica catecolaminérgica (CPVT) al dirigirse a la CaMKII en los cardiomiocitos. Este enfoque también revirtió los fenotipos de arritmia en modelos de células madre humanas de CPVT.
Área De La Ciencia
- Investigación cardiovascular
- Cardiología molecular
- Terapia génica
Sus Antecedentes
- La taquicardia ventricular polimórfica catecolaminérgica (CPVT) es una arritmia hereditaria con tratamientos actuales inadecuados.
- La proteína quinasa II dependiente de Ca2+/calmodulina (CaMKII) está implicada en la patogénesis de la CPVT.
- La inhibición selectiva de CaMKII en los cardiomiocitos es un desafío terapéutico.
Objetivo Del Estudio
- Para probar la hipótesis de que la inhibición de CaMKII dirigida a los cardiomiocitos a través de la terapia génica puede suprimir las arritmias en los modelos de CPVT.
- Evaluar la eficacia de este enfoque tanto en modelos de TPC en ratones como en humanos.
Principales Métodos
- Desarrolló AAV9-GFP-AIP, un vector viral para la inhibición de CaMKII específica de los cardiomiocitos.
- AAV9-GFP-AIP administrado de forma sistémica en modelos de ratón de CPVT.
- Se evaluó la carga de la arritmia utilizando electrofisiología y se probó el AIP en los iPSC-CM derivados del paciente.
Principales Resultados
- AAV9-GFP-AIP mostró una expresión cardíaca robusta sin efectos extracárdicos.
- Las arritmias ventriculares se suprimieron en ratones CPVT tratados con AAV9-GFP-AIP.
- Un inhibidor de CaMKII permeable a las células invirtió la liberación anormal de calcio en los iPSC-CM humanos de CPVT.
Conclusiones
- La inhibición de CaMKII mediada por AAV es una estrategia viable para suprimir las arritmias CPVT en un modelo murino.
- Este enfoque de terapia génica demostró eficacia a través de diferentes mutaciones patógenas de CPVT en los iPSC-CM humanos.
Contact us Si estos videos no son relevantes.
Contact us Si estos videos no son relevantes.
Videos de Conceptos Relacionados
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
Since enzymes help control the rate of reactions, their activity is regulated so that appropriate amounts of starting materials, intermediate metabolites, and products are maintained in the cell. Excessive build-up or depletion of...